Business Context and Reporting Period
This Form 8-K filing by Avista Healthcare Public Acquisition Corp. (not Organogenesis Holdings Inc.) reports on events occurring on June 28, 2018. The registrant is a Cayman Islands-based Special Purpose Acquisition Company (SPAC) and an emerging growth company. The filing details the results of the Annual General Meeting of shareholders held on this date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results rather than financial performance.
Material Changes and Voting Results
The following matters were submitted to a vote and approved by shareholders:
- Election of Directors: All six nominees were elected unanimously with 7,750,000 votes "FOR" and zero votes "AGAINST," "ABSTAIN," or "BROKER NON-VOTE." The elected directors are:
- Thompson Dean
- David Burgstahler
- Håkan Björklund
- Charles Harwood
- Brian Markison
- Robert O'Neil
- Ratification of Auditors: Marcum LLP was ratified as the independent auditor for the year ended December 31, 2018. The vote was 33,666,763 "FOR" with zero votes "AGAINST" or "ABSTAIN."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting the outcome of the shareholder vote.
Investor Verification Checklist
- Verify the distinction between the registrant (Avista Healthcare Public Acquisition Corp.) and the company name mentioned in the request metadata (Organogenesis Holdings Inc.).
- Confirm the total number of shares outstanding and the percentage of shares represented at the meeting to assess the significance of the voting results.
- Review subsequent filings to determine if a business combination transaction has been completed, as this is a SPAC filing.
- Check the status of the independent auditor (Marcum LLP) in subsequent periods to ensure continuity.